| 3/28/2024 | 293399809049 | VILDAGLIPTIN AMINO ALCHOL IMPURITY 90MG / (R&D PHARMACEUTICAL RAW MATERIAL) | XXXXXXXXXX | 1 | UNIT | 54 | INDIA | NA |
| 3/28/2024 | 293399809049 | LINAGLIPTIN IMPURITY METHYLQUINAZOLIN IMPURITY N-BOC LINAGLIPTIN IMPURITY 210 AD (R&D PHARMACEUTICAL RAW MATERIAL + ESSENTIAL) | XXXXXXXXXX | 0 | GRAM | 439 | INDIA | NA |
| 3/26/2024 | 293399809049 | HUMAN PHARMACEUTICAL RAW MATERIAL (CARVEDILOL)/ | XXXXXXXXXX | 160 | KILOGRAM | 35200 | China | NA |
| 3/25/2024 | 293399809049 | PHARMACEUTICAL RAW MATERIAL (OXOLAMINE PHOSPHATE) (O/XOLAMINE PHOSPHATE) | XXXXXXXXXX | 133 | KILOGRAM | 12505 | INDIA | NA |
| 3/25/2024 | 293399809049 | VILDAGLIPTIN (HUMAN PHARMACEUTICAL RAW MATERIAL)/ | XXXXXXXXXX | 1199 | KILOGRAM | 123582 | INDIA | NA |
| 3/25/2024 | 293399809049 | ATORVASTATIN CALCIUM - NITROGENOUS HETEROCYCLIC COMPOUNDS (PHARMACEUTICAL RAW MATERIAL) - ATORVASTATIN IS A STATIN DRUG USED TO PREVENT CARDIOVASCULAR DISEASES AND TO TREAT ABORMAL LIPID LEVELS IN PERSONS AT HIGH RISK. | XXXXXXXXXX | 200 | KILOGRAM | 32000 | INDIA | NA |
| 3/22/2024 | 293399809049 | DAPAGLIFLOZIN (WILL BE USED IN THE HUMAN PHARMACEUTICAL INDUSTRY FOR A/ANALYSIS) (40 MG) | XXXXXXXXXX | 0 | GRAM | 895 | INDIA | NA |
| 3/21/2024 | 293399809049 | VALSARTAN (PHARMACEUTICAL RAW MATERIAL SAMPLE) [V/ALSARTAN] | XXXXXXXXXX | 70 | GRAM | 254 | INDIA | NA |
| 3/20/2024 | 293399809049 | HUMAN PHARMACEUTICAL RAW MATERIAL (AZELASTINE HYDR/OCHLORIDE) | XXXXXXXXXX | 0 | KILOGRAM | 3750 | INDIA | NA |
| 3/20/2024 | 293399809049 | HUMAN PHARMACEUTICAL RAW MATERIAL (AZELASTINE HYDR/OCHLORIDE) | XXXXXXXXXX | 100 | GRAM | 750 | INDIA | NA |